New perspectives in Respiratory Syncitial Virus infection

References

• Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncitial virus in young children: a systematic review and meta-analysis. Lancet 2010;375:1545–55
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Respiratory syncitial virus. In: Pickering LK, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village: Churchill Livingstone; 2012:609–18
   Google Scholar
• Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncitial virus infection in young children. N Engl J Med 2009;360:588–98
   PubMed Web of Science ®Google Scholar
• Masaki T, Kojima T, Okabayashi T, et al. A nuclear factor-κB signaling pathway via protein kinase C δ regulates replication of respiratory syncitial virus in polarized normal human nasal epithelial cells. Mol Biol Cell 2011;22:2144–56
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Lindell DM, Berlin AA, et al. IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am J Pathol 2011;179:248–58
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 2006;118:1774–93
   PubMed Web of Science ®Google Scholar
• Purcell K, Fergie J. Driscoll Children's Hospital respiratory syncitial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002. Pediatr Infect Dis J 2004;23:418–23
   PubMedGoogle Scholar
• Hyvärinen MK, Kotaniemi-Syrjänen A, Reijonen TM, et al. Lung function and bronchial hyper-responsiveness 11 years after hospitalization for bronchiolitis. Acta Paediatr 2007;96:1464–9
   PubMedGoogle Scholar
• Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncitial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005;171:137–41
   PubMed Web of Science ®Google Scholar
• Henderson J, Hilliard TN, Sherriff A, et al. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol 2005;16:386–92
   PubMed Web of Science ®Google Scholar
• Sigurs N, Aljassim F, Kjellman B, et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 2010;65:1045–52
   PubMed Web of Science ®Google Scholar
• Ruotsalainen M, Piippo-Savolainen E, Hyvärinen MK, Korppi M. Respiratory morbidity in adulthood after respiratory syncitial virus hospitalization in infancy. Pediatr Infect Dis J 2010;29:872–4
   PubMed Web of Science ®Google Scholar
• Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncitial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354:541–5
   PubMed Web of Science ®Google Scholar
• Broughton S, Roberts A, Fox G, et al. Prospective study of healthcare utilisation and respiratory morbidity due to RSV infection in prematurely born infants. Thorax 2005;60:1039–44
   PubMed Web of Science ®Google Scholar
• Romero JR, Stewart DL, Buysman EK, et al. Serious early childhood wheezing after respiratory syncitial virus lower respiratory tract illness in preterm infants. Clin Ther 2010;32:2422–32
   PubMed Web of Science ®Google Scholar
• Escobar GJ, Ragins A, Li SX, et al. Recurrent wheezing in the third year of life among children born at 32 weeks' gestation or later: relationship to laboratory-confirmed, medically attended infection with respiratory syncitial virus during the first year of life. Arch Pediatr Adolesc Med 2010;164:915–22
   PubMedGoogle Scholar
• Blanken MO, Rovers MM, Molenaar JM, et al. Dutch RSV Neonatal Network. Respiratory syncitial virus and recurrent wheeze in healthy preterm infants. N Engl J Med 2013;368:1791–9
   PubMed Web of Science ®Google Scholar
• Sweetman LL, Ng YT, Butler IJ, Bodensteiner JB. Neurologic complications associated with respiratory syncitial virus. Pediatr Neurol 2005;32:307–10
   PubMed Web of Science ®Google Scholar
• Millichap JJ, Wainwright MS. Neurological complications of respiratory syncitial virus infection: case series and review of literature. J Child Neurol 2009;24:1499–503
   PubMedGoogle Scholar
• Kho N, Kerrigan JF, Tong T, et al. Respiratory syncytial virus infection and neurologic abnormalities: retrospective cohort study. J Child Neurol 2004;19:859–64
   PubMed Web of Science ®Google Scholar
• Zlateva KT, Van Ranst M. Detection of subgroup B respiratory syncitial virus in the cerebrospinal fluid of a patient with respiratory syncitial virus pneumonia. Pediatr Infect Dis J 2004;23:1065–6
   PubMed Web of Science ®Google Scholar
• Playfor SD, Khader A. Arrhythmias associated with respiratory syncitial virus infection. Pediatr Anesthesia 2005;15:1016–8
   PubMedGoogle Scholar
• Sreeram N, Watson JG, Hunter S. Cardiovascular effects of acute bronchiolitis. Acta Paediatr Scand 1991;80:133–6
   PubMedGoogle Scholar
• Bowles NE, Ni J, Kearney DL, et al. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003;42:466–72
   PubMed Web of Science ®Google Scholar
• Eisenhut M, Thorburn K. Hepatitis associated with severe respiratory syncitial virus-positive lower respiratory tract infection. Scand J Infect Dis 2002;34:235
   PubMed Web of Science ®Google Scholar
• Eisenhut M, Thorburn K, Ahmed T. Transaminase levels in ventilated children with respiratory syncytial virus bronchiolitis. Intensive Care Med 2004;30:931–4
   PubMedGoogle Scholar
• Nadal D, Wunderli W, Meurmann O, et al. Isolation of respiratory syncytial virus from liver tissue and extrahepatic biliary atresia material. Scand J Infect Dis 1990;22:91–3
   PubMed Web of Science ®Google Scholar
• Paes BA, Mitchell I, Banerji A, et al. A decade of respiratory syncitial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice. Can Respir J 2011;18:e10–19
   Google Scholar
• Andabaka T, Nickerson JW, Rojas-Reyes MX, et al. Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children. Cochrane Database Syst Rev 2013;4:CD006602
   PubMed Web of Science ®Google Scholar
• Borchers AT, Chang C, Gershwin ME, Gershwin LJ. Respiratory syncitial virus-A comprehensive review. Clinic Rev Allerg Immunol 2013. [Epub ahead of print]
   PubMedGoogle Scholar
• Samson L. Prevention of respiratory syncytial virus infection. Paediatr Child Health 2009;14:521–32
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Policy statement-modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics 2009;124:1694–701
   PubMedGoogle Scholar
• Carbonell-Estrany X, Simões EA, Dagan R, et al; Motavizumab Study Group. Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial. Pediatrics 2010;125:e35–51
   PubMed Web of Science ®Google Scholar
• Smart KA, Lanctôt KL, Paes BA. The cost effectiveness of palivizumab: a systematic review of the evidence. J Med Econ 2010;13:453–63
   PubMedGoogle Scholar
• Yount LE, Mahle WT. Economic analysis of palivizumab in infants with congenital heart disease. Pediatrics 2004;114:1606–11
   PubMed Web of Science ®Google Scholar
• Raccomandazioni della Società Italiana di Neonatologia per la prevenzione delle malattie da virus respiratorio sinciziale (VRS). Aggiornamento del 2004. Acta Neonatolog Pediatr 2004;1:19–29
   Google Scholar
• Krilov LR, Weiner LB, Yogev R, et al. The 2009 COID recommendations for RSV prophylaxis: issues of efficacy, cost, and evidence-based medicine. Pediatrics 2009;124:1682–4
   PubMed Web of Science ®Google Scholar
• Figueras-Aloy J, Carbonell-Estrany X, Quero J; IRIS Study Group. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33–35 weeks in Spain. Pediatr Infect Dis J 2004;23:815–20
   PubMed Web of Science ®Google Scholar
• Law BJ, Langley JM, Allen U, et al. The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J 2004;23:806–14
   PubMed Web of Science ®Google Scholar
• Lanari M, Adorni F, Silvestri M, et al. ‘Italian Study Group on Risk Factors for RSV-related Hospitalization. The multicenter Italian birth cohort study on incidence and determinants of lower respiratory tract infection hospitalization in infants at 33 weeks GA or more: Preliminary results. Early Hum Dev 2011;87:S43–6
   PubMed Web of Science ®Google Scholar